UBS Group Lowers Owens & Minor (NYSE:OMI) Price Target to $25.00

Owens & Minor (NYSE:OMI) had its target price reduced by equities research analysts at UBS Group from $28.00 to $25.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group’s price objective suggests a potential upside of 114.59% from the stock’s previous close.

Several other equities analysts have also commented on the company. StockNews.com lowered Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Robert W. Baird lowered their price objective on Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday. Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. lowered their price objective on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research report on Wednesday, August 21st. Finally, Barclays decreased their price objective on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a research report on Tuesday. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, Owens & Minor currently has an average rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Price Performance

Shares of Owens & Minor stock traded down $0.35 on Tuesday, reaching $11.65. The stock had a trading volume of 509,669 shares, compared to its average volume of 831,391. The company has a current ratio of 1.09, a quick ratio of 0.51 and a debt-to-equity ratio of 2.17. The business’s 50 day moving average is $14.54 and its two-hundred day moving average is $16.19. The company has a market cap of $898.22 million, a P/E ratio of -20.80, a price-to-earnings-growth ratio of 0.43 and a beta of 0.41. Owens & Minor has a 1 year low of $11.42 and a 1 year high of $28.35.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.01. The firm had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The company’s revenue was up 5.0% on a year-over-year basis. During the same period last year, the company earned $0.44 earnings per share. As a group, research analysts anticipate that Owens & Minor will post 1.57 EPS for the current year.

Institutional Investors Weigh In On Owens & Minor

A number of large investors have recently bought and sold shares of the stock. Quarry LP raised its position in Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company’s stock worth $28,000 after acquiring an additional 1,561 shares during the period. Blue Trust Inc. raised its holdings in Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after buying an additional 1,780 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Owens & Minor by 43,142.9% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,027 shares of the company’s stock worth $84,000 after purchasing an additional 3,020 shares in the last quarter. DekaBank Deutsche Girozentrale grew its position in shares of Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock worth $43,000 after buying an additional 1,356 shares during the period. Finally, Innealta Capital LLC purchased a new stake in shares of Owens & Minor in the 2nd quarter worth about $43,000. 98.04% of the stock is currently owned by institutional investors and hedge funds.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.